Most Popular |

Mike Havrilla

1844
Followers

5
Following

Sort by:

Latest | Editors' Picks | Most Commented | Most Popular

EXACT Sciences: Buy and Hold for Long-Term Upside
on Nov 08, 2009 • EXAS
Access Pharma Looking for Smooth U.S. MuGard Launch in 2010
on Nov 11, 2009 • ACCP.OB
Extreme FDA Trades: 30 Stocks Under 5 Bucks
on Aug 02, 2009 • ACAD, ADLS.OB, AEZS
FDA Calendar Extreme Trades: 85 Single Digit Stocks
on Oct 14, 2009 • DYAX, HEB, HGSI
A 130 / 30 Global Pharma Strategy
on Nov 05, 2009 • AZN, GSK, MRK
ImmunoCellular's Promising Brain Cancer Vaccine
on Oct 28, 2009 • AGEN, CLDX, EXEL
BioMed News Bytes: Dyax, Human Genome Sciences, Aldagen
on Oct 29, 2009 • DYAX, HGSI
October FDA Calendar Stocks: Tricks or Treats?
on Oct 16, 2009 • AMGN, BPAX, GSK
Updates on Access Pharma, BioSphere Medical, CryoLife, NeoPharm
on Oct 28, 2009 • ACCP.OB, BSMD, CRY
BioMed Momentum Index: A Pause that Refreshes or More Pain to Come?
on Oct 29, 2009 • AGEN, BCRX, CVM
Railroad Stocks Steam Ahead on Buffett’s Buy of BNI
on Nov 03, 2009 • BNI, BRK.A, BRK.B
Unilife: Medical Device Innovator Creating Jobs in Pennsylvania
on Oct 30, 2009 • SNY, UNIFF.PK, WST
Celldex Therapeutics: Plenty of Cash, Pending Clinical Catalysts
on Oct 20, 2009 • CLDX
BioMed News: Antigenics, Shire, King Pharma, Delcath Systems
on Oct 21, 2009 • AGEN, DCTH, KG
32 Stem Cell Companies to Watch
on Feb 04, 2009 • ACTC, ASTM, ATHX
EXACT Sciences: Patience Required for Long-Term Upside
on Nov 04, 2009 • EXAS
Healthcare ETFs Are Outpacing the Market
on Nov 01, 2008 • BBH, DBR, FBT
BioMed News Bytes: Angiotech, BioSante, HGSI
on Oct 20, 2009 • ANPI, BPAX, GSK
Pending FDA Decisions: 12 Extreme Trades
on May 20, 2009 • ABIO, ADLS, BDSI
Biotech News Bytes: Johnson & Johnson, CombinatoRx, Covidien
on Sep 27, 2009 • COV, CRXX, JNJ
Momenta Pharma's M-Enoxaparin: Timing Uncertain, Approval Likely
on Oct 07, 2009 • MNTA
Top 10 Emerging Biotech Stocks
on Oct 15, 2007 • ADLS, EXAS, GTCB
Pending FDA Decisions: 20 Extreme Trades
on Jun 22, 2009 • ACUR, ADLS, APPA
BioMed News: Rockwell Medical, EXACT Sciences, MannKind
on Oct 30, 2009 • EXAS, MNKD, RMTI
Access Pharma: MuGard, Pipeline Make for Appealing Acquisition Possibilities
on Sep 30, 2009 • ACCP.OB, ALTH, BIIB
Healthcare: Investing Trends for 2009
on Dec 19, 2008 • AET, AFL, AMSF
Extreme FDA Trades: Another 18 Stocks Under 5 Bucks
on Jul 05, 2009 • ACAD, AGEN, ALXA
FDA Calendar: 2H09 Binary Event Trades
on Jul 27, 2009 • ACAD, AEZS, ALKS
Inovio Biomedical: DNA Vaccine Delivery Innovator
on Oct 09, 2009 • INO, MRK
Upcoming FDA Decisions and Clinical Trials: Prevacid Goes OTC, Swine Flu Test
on May 15, 2009 • ALTH, CADX, NVS
Small Cap Stocks Battling Brain Cancer
on Sep 07, 2009 • ARKTF.PK, BMY, CLDX
FDA Calendar Updates: Johnson & Johnson, Cadence, Watson, Targacept
on Jul 16, 2009 • CADX, JNJ, TRGT

Articles by Ticker

AA, AAI, AAPL, AAWW, ABBC, ABFS, ABII, ABIO, ABMD, ABT, ABTL, ABV, ABX, ACAD, ACCP.OB, ACEL, ACHN, ACL, ACLI, ACOR, ACTC, ACTC.PK, ACUR, ACUS, ADAM, ADLR, ADLS, ADLS.OB, AET, AEZS, AFFX, AFFY, AFL, AGEN, AGN, AHBIF.PK, AIQ, AIRM, AIS, AKRX, ALEX, ALGT, ALK, ALKS, ALNPY.PK, ALNY, ALO, ALPMF.PK, ALTH, ALV,

Latest Comments on Mike Havrilla's Articles

unblock school on Novartis: An Ex-U.S. Proxy for Global Healthcare: Thanks for great post Mike, Delta more »
drgmoney on Access Pharma Looking for Smooth U.S. MuGard Launch in 2010: Do you know if the post marketing Data on Mugard in Europe will be... more »
jay brebner on EXACT Sciences: Buy and Hold for Long-Term Upside: Thanks Charlie - I didn't know the stats off the top of my head... more »
Super Stock Timer on BioMed News Bytes: Cytori, Questcor: 11-7-09 - BUY DNDN ON THE FIRST CLOSE ABOVE 29.00 - WALTER - SUPER... more »
Charlie L on EXACT Sciences: Buy and Hold for Long-Term Upside: Agree that $300 every 3 years is a bargain compared to a $2,000... more »
jay brebner on EXACT Sciences: Buy and Hold for Long-Term Upside: $300 per test is an absolute bargain to detect CRC early. the... more »
BioGuy on A 130 / 30 Global Pharma Strategy : Good ideas, the generic pharmaceutical market will do well. My... more »
Dr. Bone on A 130 / 30 Global Pharma Strategy : This index sounds very interesting. Is there a way you can... more »
TX Gal 4Evr on Railroad Stocks Steam Ahead on Buffett’s Buy of BNI: Have you not heard of 'change' or 'growth' or 'variety'?? It's... more »
dual cit on Railroad Stocks Steam Ahead on Buffett’s Buy of BNI: Not what I want to hear from you. I have grown accustomed to you... more »
hoopdreamerz@yahoo.com on EXACT Sciences: Patience Required for Long-Term Upside: That's funny they compared their data with OncoMethylone (i had... more »
researchbio48 on Bio-Pharma, Diagnostics Buyout Binge Begins: Hi Mike - not sure how often you upday this link but I was hoping... more »
Mike Havrilla on Unilife: Medical Device Innovator Creating Jobs in Pennsylvania: NEH, The major investment and agreement with Sanofi (SNY) may give... more »
NEH on Unilife: Medical Device Innovator Creating Jobs in Pennsylvania: I love it Mike - it's exactly the kind of under-the-radar... more »
tappy on BioSante Pharma's LibiGel: Big Upside Potential: I have read your comments on Libi-Gel and they are well research... more »

Latest Comments on Mike Havrilla's Articles

Mike Havrilla » Articles » Most Popular |

Sort by:

Articles by Ticker

Latest Comments on Mike Havrilla's Articles

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers